Literature DB >> 26242988

The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome.

Sarah Joyce1, Kristiana Gordon2, Glen Brice1, Pia Ostergaard3, Rani Nagaraja4, John Short1, Sandra Moore1, Peter Mortimer3, Sahar Mansour1,3.   

Abstract

The RASopathies, which include Noonan syndrome (NS) and Cardiofaciocutaneous syndrome (CFC), are autosomal dominant disorders with genetic heterogeneity associated with germline mutations of genes in the Ras/mitogen-activated protein kinase (MAPK; RAS-MAP kinase) pathway. The conditions overlap and are characterised by facial dysmorphism, short stature and congenital heart disease. NS and CFC, in particular, are known to be associated with lymphatic problems, but this has not been well characterised to date. We describe 11 patients with Noonan or CFC syndrome with significant, persistent and progressive lymphatic dysplasia. The lymphatic disorders in Noonan and CFC syndrome are rare, but have a characteristic pattern with bilateral lower limb lymphoedema, genital swelling with chylous reflux and frequent systemic involvement, including intestinal lymphangiectasia and chylothoraces, which may be progressive. Lymphoscintigraphy demonstrates reflux and/or rerouting of lymphatic drainage associated with incompetent veins on the venous duplex scans.

Entities:  

Mesh:

Year:  2015        PMID: 26242988      PMCID: PMC4930084          DOI: 10.1038/ejhg.2015.175

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  CHYLOUS REFLUX.

Authors:  J B KINMONTH; G W TAYLOR
Journal:  Br Med J       Date:  1964-02-29

2.  Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.

Authors:  Helen L Hanson; Meredith J Wilson; John P Short; Barry A Chioza; Andrew H Crosby; Ruth M Nash; Karen J Marks; Sahar Mansour
Journal:  Am J Med Genet A       Date:  2014-01-23       Impact factor: 2.802

3.  Spectrum of mutations in Noonan syndrome and their correlation with phenotypes.

Authors:  Beom Hee Lee; Jae-Min Kim; Hye Young Jin; Gu-Hwan Kim; Jin-Ho Choi; Han-Wook Yoo
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

4.  On congenital lymphedema.

Authors:  J M Opitz
Journal:  Am J Med Genet       Date:  1986-05

5.  Medical complications, clinical findings, and educational outcomes in adults with Noonan syndrome.

Authors:  Patroula Smpokou; Erica Tworog-Dube; Raju S Kucherlapati; Amy E Roberts
Journal:  Am J Med Genet A       Date:  2012-11-19       Impact factor: 2.802

Review 6.  Lymphedema in Noonan syndrome: clues to pathogenesis and prenatal diagnosis and review of the literature.

Authors:  D R Witt; H E Hoyme; J Zonana; D K Manchester; J P Fryns; J G Stevenson; C J Curry; J G Hall
Journal:  Am J Med Genet       Date:  1987-08

7.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

8.  New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement--the CFC syndrome.

Authors:  J F Reynolds; G Neri; J P Herrmann; B Blumberg; J G Coldwell; P V Miles; J M Opitz
Journal:  Am J Med Genet       Date:  1986-11

9.  Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.

Authors:  Caroline Nava; Nadine Hanna; Caroline Michot; Sabrina Pereira; Nathalie Pouvreau; Tetsuya Niihori; Yoko Aoki; Yoichi Matsubara; Benoit Arveiler; Didier Lacombe; Eric Pasmant; Béatrice Parfait; Clarisse Baumann; Delphine Héron; Sabine Sigaudy; Annick Toutain; Marlène Rio; Alice Goldenberg; Bruno Leheup; Alain Verloes; Hélène Cavé
Journal:  J Med Genet       Date:  2007-08-17       Impact factor: 6.318

10.  Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.

Authors:  Lisenka E L M Vissers; Monica Bonetti; Jeroen Paardekooper Overman; Willy M Nillesen; Suzanna G M Frints; Joep de Ligt; Giuseppe Zampino; Ana Justino; José C Machado; Marga Schepens; Han G Brunner; Joris A Veltman; Hans Scheffer; Piet Gros; José L Costa; Marco Tartaglia; Ineke van der Burgt; Helger G Yntema; Jeroen den Hertog
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

View more
  22 in total

Review 1.  An approach to familial lymphoedema.

Authors:  Gabriela E Jones; Sahar Mansour
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

2.  RASA1 regulates the function of lymphatic vessel valves in mice.

Authors:  Philip E Lapinski; Beth A Lubeck; Di Chen; Abbas Doosti; Scott D Zawieja; Michael J Davis; Philip D King
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

3.  Congenital Chylothorax as the Initial Presentation of PTPN11-Associated Noonan Syndrome.

Authors:  Darius Ebrahimi-Fakhari; Eli Freiman; Monica H Wojcik; Katie Krone; Alicia Casey; Ariel S Winn; Amy E Roberts; Beth D Harper
Journal:  J Pediatr       Date:  2017-03-28       Impact factor: 4.406

4.  ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.

Authors:  Dong Li; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Christoph Seiler; Erin Pinto; Leticia S Matsuoka; Mark R Battig; Elizabeth J Bhoj; Tara L Wenger; Lifeng Tian; Nora Robinson; Tiancheng Wang; Yichuan Liu; Brant M Weinstein; Matthew Swift; Hyun Min Jung; Courtney N Kaminski; Rosetta Chiavacci; Jonathan A Perkins; Michael A Levine; Patrick M A Sleiman; Patricia J Hicks; Janet T Strausbaugh; Jean B Belasco; Yoav Dori; Hakon Hakonarson
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

5.  Dynamic Contrast Magnetic Resonance Lymphangiography Localizes Lymphatic Leak to the Duodenum in Protein-Losing Enteropathy.

Authors:  Jefferson N Brownell; David M Biko; Petar Mamula; Ganesh Krishnamurthy; Fernando Escobar; Abhay Srinivasan; Pablo Laje; David A Piccoli; Erin Pinto; Christopher L Smith; Yoav Dori
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-01-01       Impact factor: 3.288

Review 6.  Systematic literature review of lymphatic imaging-guided procedural management of Noonan syndrome.

Authors:  Taylor Paul Cox; Christopher James Vance; Sarah K Daley; Cristobal Papendieck; Hugh McGregor; Philip Kuo; Marlys H Witte
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2022-05-10

7.  Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly.

Authors:  Mandi Liu; Christopher L Smith; David M Biko; Dong Li; Erin Pinto; Nora O'Connor; Cara Skraban; Elaine H Zackai; Hakon Hakonarson; Yoav Dori; Sarah E Sheppard
Journal:  Eur J Hum Genet       Date:  2022-05-24       Impact factor: 5.351

8.  Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly.

Authors:  Dong Li; Tara L Wenger; Christoph Seiler; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Elizabeth Bhoj; Lifeng Tian; Misha Rosenbach; Yichuan Liu; Nora Robinson; Mechenzie Behr; Rosetta Chiavacci; Cuiping Hou; Tiancheng Wang; Marina Bakay; Renata Pellegrino da Silva; Jonathan A Perkins; Patrick Sleiman; Michael A Levine; Patricia J Hicks; Maxim Itkin; Yoav Dori; Hakon Hakonarson
Journal:  Hum Mol Genet       Date:  2018-09-15       Impact factor: 6.150

9.  The molecular functions of RIT1 and its contribution to human disease.

Authors:  Richard Van; Antonio Cuevas-Navarro; Pau Castel; Frank McCormick
Journal:  Biochem J       Date:  2020-08-14       Impact factor: 3.857

10.  Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow.

Authors:  Kelly L Betterman; Drew L Sutton; Genevieve A Secker; Jan Kazenwadel; Anna Oszmiana; Lillian Lim; Naoyuki Miura; Lydia Sorokin; Benjamin M Hogan; Mark L Kahn; Helen McNeill; Natasha L Harvey
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.